ClinicalTrials.Veeva

Menu

Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke

Mass General Brigham logo

Mass General Brigham

Status

Active, not recruiting

Conditions

Hemorrhagic Stroke

Treatments

Other: In-patient and out-patient electronic health record alert

Study type

Interventional

Funder types

Other

Identifiers

NCT05643001
2021P001597

Details and patient eligibility

About

The overall goal of this study is to increase health care provider awareness for common risk factors and comorbidities in patients with hemorrhagic stroke that are related to impaired brain health, to ultimately improve patients management and associated outcomes. The specific objective is to test the performance and effectiveness of a custom electronic health record (EHR)-based notification module at time of index hospitalization and at follow-up for hemorrhagic stroke survivors, before disparities in access to outpatient care may limit opportunities to intervene.

The investigators hypothesize that notification of health care providers through the EHR will increase measurements of low-density lipoprotein (LDL) and glycated hemoglogbin A1c (HbA1c) and increase evaluation and management rates for obstructive sleep apnea and hearing impairment.

Enrollment

340 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 years or older
  • Presenting with a primary diagnosis of hemorrhagic stroke admitted to Massachusetts General Hospital inpatient stroke service

Exclusion criteria

  • Patients not meeting above inclusion criteria
  • Patients presenting with subdural or epidural hematoma

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

340 participants in 1 patient group

Electronic Health Record Notification
Experimental group
Description:
For eligible patients presenting with an acute hemorrhagic stroke, a recommendation to measure low-density lipoprotein (LDL) and glycated hemoglobin A1c (HbA1c) together with their last measurement dates will be displayed in the patient's electronic health record through a best practice alert (BPA). The alert will display for the patient's provider when they first open the patient's chart. The provider may accept the automatically generated orders for both measurements displayed in the BPA, may modify one or both of the orders, or choose to dismiss the BPA. For patients that follow-up with the out-patient stroke clinic and received the in-patient intervention, a second BPA will suggest referrals to sleep study and audiology. The alert will display for the patient's provider when they first open the patient's chart. The provider may accept one or both of the referrals suggested by the BPA, or may choose to dismiss the BPA.
Treatment:
Other: In-patient and out-patient electronic health record alert

Trial contacts and locations

1

Loading...

Central trial contact

Christopher D Anderson, MD MMSc; Ernst Mayerhofer, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems